Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

ClinicalTrials.gov ID: NCT00606593

Public ClinicalTrials.gov record NCT00606593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 13, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 2-night polysomnography / 5-way cross-over study to evaluate the effect, safety and tolerability of oral administration of almorexant (ACT 078573) in elderly subjects with primary insomnia.

Study identification

NCT ID
NCT00606593
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Midnight Pharma, LLC
Industry
Enrollment
112 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Mar 31, 2008
Completion
Apr 30, 2008
Last update posted
Mar 13, 2016

2007 – 2008

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Central Arkansas Research Hot Springs Arkansas 71913
Pacific Sleep Medicine Services, Inc. Los Angeles California 90048
Pacific Sleep Medicine Services, Inc. San Diego California 92121
California Clinical Trials Medical Group, Inc. San Diego California 92123
PAB Clinical Research Brandon Florida 33511
Miami Research Associates Miami Florida 33173
OmniTrials Naples Florida 34110
Broward Research Group & Sleep-Wake Disorders Center of South Florida Pembroke Pines Florida 33026
Neurotrials Research, Inc. Atlanta Georgia 30342
Sleep Disorders Center of Georgia Atlanta Georgia 30342
Vince and Associates Clinical Research Overland Park Kansas 66212
Community Research Crestview Hills Kentucky 41017
Clinical Neurophysiology Services, P.C. Troy Michigan 48098
Sleep Disorders & Research Center Chesterfield Missouri 63017
Clinical Research Center of Nevada Las Vegas Nevada 89104
Duke University Durham North Carolina 27710
Tri-State Sleep Disorders Center Cincinnati Ohio 45227
Cleveland Clinic Health Systems Cleveland Ohio 44195
Lynn Health Sciences Institute Oklahoma City Oklahoma 73112
Sleep Disorders Center Columbia South Carolina 29201
Sleep Medicine Associates P.A. Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00606593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2016 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00606593 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →